TREATMENT OF A TRABECULAR MESHWORK WHOSE CELLS ARE SUBJECT TO INHIBITION OF CELL DIVISION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

摘要

The invention concerns the recognition that certain non-steroidal antiinflammatory agents can overcome or ameliorate limitations on trabecular meshwork cell division produced by environmental stresses (e.g., oxidative or phagocytic injury, or glucocorticoid exposure), and thus can be used to prevent or treatloss of trabecular cells found in certain forms of glaucoma and in normal aging. The use of such non-steroidal anti-inflammatory agents can ameliorate the severity, or prevent glaucoma.